Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Inv. presentation
|
|
ISTA PHARMACEUTICALS INC (ISTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2012 |
4
| MCGINLEY KATHLEEN (VP, HR and Corp. Services) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| McNamara Timothy (VP Clinical Research & Medical) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| ROE WAYNE I (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| ANIDO VICENTE JR (President & CEO) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 537,116 shares
@ $9.1, valued at
$4.9M
Disposed/sold 172,775 shares
@ $9.1, valued at
$1.6M
Disposed/sold 13,613 shares
@ $9.1, valued at
$123.9k
Disposed/sold 13,612 shares
@ $9.1, valued at
$123.9k
Disposed/sold 236,350 options to buy
@ $3.75, valued at
$886.3k
Disposed/sold 17,852 options to buy
@ $6.82, valued at
$121.8k
Disposed/sold 145,798 options to buy
@ $6.82, valued at
$994.3k
Disposed/sold 123,789 options to buy
@ $3.63, valued at
$449.4k
Disposed/sold 36,758 options to buy
@ $3.63, valued at
$133.4k
Disposed/sold 30,685 options to buy
@ $1.04, valued at
$31.9k
Disposed/sold 115,914 options to buy
@ $1.04, valued at
$120.6k
|
|
| 06/15/2012 |
4
| MCMULLIN KIRK (VP, Operations) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| PERLMAN ANDREW J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| WILLIAMS RICHARD C (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 116,032 shares
@ $9.1, valued at
$1.1M
Disposed/sold 20,000 options to buy
@ $3.89, valued at
$77.8k
Disposed/sold 20,000 options to buy
@ $4.58, valued at
$91.6k
Disposed/sold 20,000 options to buy
@ $4.72, valued at
$94.4k
Disposed/sold 11,100 options to buy
@ $0.79, valued at
$8.8k
Disposed/sold 11,100 options to buy
@ $6.9, valued at
$76.6k
Disposed/sold 16,000 options to buy
@ $6.08, valued at
$97.3k
Disposed/sold 16,000 options to buy
@ $5.82, valued at
$93.1k
Disposed/sold 9,000 options to buy
@ $10.75, valued at
$96.8k
Disposed/sold 16,250 options to buy
@ $6.96, valued at
$113.1k
Disposed/sold 32,500 options to buy
@ $3.49, valued at
$113.4k
|
|
| 06/15/2012 |
4
| Davis Glenn Eugene (VP Legal, Chief Compl. Officer) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| Drazba Brian G. (VP, Finance & CAO) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 40,487 shares
@ $9.1, valued at
$368.4k
Disposed/sold 29,935 options to buy
@ $3.75, valued at
$112.3k
Disposed/sold 1,940 options to buy
@ $3.75, valued at
$7.3k
Disposed/sold 4,834 options to buy
@ $4.58, valued at
$22.1k
Disposed/sold 8,500 options to buy
@ $4.58, valued at
$38.9k
Disposed/sold 5,828 options to buy
@ $3.63, valued at
$21.2k
Disposed/sold 7,875 options to buy
@ $3.71, valued at
$29.2k
|
|
| 06/15/2012 |
4
| MITRO THOMAS A (VP, Sales & Marketing) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| SILVERNAIL LAUREN P (CFO & VP Corporate Development) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| MCGRAW BENJAMIN F III (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 06/15/2012 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,932 shares
@ $9.1, valued at
$44.9k
Disposed/sold 20,000 options to buy
@ $3.89, valued at
$77.8k
Disposed/sold 20,000 options to buy
@ $4.58, valued at
$91.6k
Disposed/sold 20,000 options to buy
@ $4.72, valued at
$94.4k
Disposed/sold 11,100 options to buy
@ $0.79, valued at
$8.8k
Disposed/sold 11,100 options to buy
@ $6.9, valued at
$76.6k
Disposed/sold 16,000 options to buy
@ $6.08, valued at
$97.3k
Disposed/sold 16,000 options to buy
@ $5.82, valued at
$93.1k
Disposed/sold 32,500 options to buy
@ $10.17, valued at
$330.5k
|
|
| 06/15/2012 |
4
| GARRETT MARVIN J (Vice President, QC, Compliance) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 05/23/2012 |
4
| MITRO THOMAS A (VP, Sales & Marketing) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 28,084 shares
@ $9.08, valued at
$255k
Paid exercise price by delivering 482 shares
@ $9.08, valued at
$4.4k
Paid exercise price by delivering 11,433 shares
@ $9.08, valued at
$103.8k
Paid exercise price by delivering 12,871 shares
@ $9.08, valued at
$116.9k
Paid exercise price by delivering 10,698 shares
@ $9.08, valued at
$97.1k
Paid exercise price by delivering 2,489 shares
@ $9.08, valued at
$22.6k
Paid exercise price by delivering 3,943 shares
@ $9.08, valued at
$35.8k
Paid exercise price by delivering 837 shares
@ $9.08, valued at
$7.6k
Exercised 21,731 options to buy
@ $1.04, valued at
$22.6k
Exercised 1,253 options to buy
@ $3.49, valued at
$4.4k
Exercised 9,862 options to buy
@ $3.63, valued at
$35.8k
|
|
| 05/22/2012 |
4
| McNamara Timothy (VP Clinical Research & Medical) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,745 shares
@ $9.07, valued at
$88.4k
Paid exercise price by delivering 14,110 shares
@ $9.07, valued at
$128k
Paid exercise price by delivering 5,566 shares
@ $9.07, valued at
$50.5k
Paid exercise price by delivering 5,450 shares
@ $9.07, valued at
$49.4k
Paid exercise price by delivering 1,462 shares
@ $9.07, valued at
$13.3k
Paid exercise price by delivering 5,103 shares
@ $9.07, valued at
$46.3k
Paid exercise price by delivering 3,232 shares
@ $9.07, valued at
$29.3k
Exercised 12,752 options to buy
@ $1.04, valued at
$13.3k
Exercised 12,750 options to buy
@ $3.63, valued at
$46.3k
Exercised 11,084 options to buy
@ $4.46, valued at
$49.4k
Exercised 19,934 options to buy
@ $6.42, valued at
$128k
|
|
| 05/21/2012 |
4
| MCMULLIN KIRK (VP, Operations) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 11,424 shares
@ $9.06, valued at
$103.5k
Paid exercise price by delivering 7,229 shares
@ $9.06, valued at
$65.5k
Paid exercise price by delivering 10,217 shares
@ $9.06, valued at
$92.6k
Paid exercise price by delivering 11,129 shares
@ $9.06, valued at
$100.8k
Paid exercise price by delivering 9,200 shares
@ $9.06, valued at
$83.4k
Paid exercise price by delivering 1,423 shares
@ $9.06, valued at
$12.9k
Paid exercise price by delivering 4,966 shares
@ $9.06, valued at
$45k
Paid exercise price by delivering 3,351 shares
@ $9.06, valued at
$30.4k
Exercised 12,396 options to buy
@ $1.04, valued at
$12.9k
Exercised 18,767 options to buy
@ $3.49, valued at
$65.5k
Exercised 12,395 options to buy
@ $3.63, valued at
$45k
|
|
| 05/21/2012 |
4
| GARRETT MARVIN J (Vice President, QC, Compliance) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 20,338 shares
@ $9.06, valued at
$184.3k
Paid exercise price by delivering 10,595 shares
@ $9.06, valued at
$96k
Paid exercise price by delivering 8,624 shares
@ $9.06, valued at
$78.1k
Paid exercise price by delivering 1,708 shares
@ $9.06, valued at
$15.5k
Paid exercise price by delivering 4,940 shares
@ $9.06, valued at
$44.8k
Paid exercise price by delivering 1,967 shares
@ $9.06, valued at
$17.8k
Paid exercise price by delivering 33,630 shares
@ $9.06, valued at
$304.7k
Exercised 14,878 options to buy
@ $1.04, valued at
$15.5k
Exercised 87,303 options to buy
@ $3.49, valued at
$304.7k
Exercised 12,329 options to buy
@ $3.63, valued at
$44.8k
Exercised 17,518 options to buy
@ $4.46, valued at
$78.1k
|
|
| 05/14/2012 |
4
| MCGINLEY KATHLEEN (VP, HR and Corp. Services) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 10,898 shares
@ $9.09, valued at
$99.1k
Paid exercise price by delivering 10,902 shares
@ $9.09, valued at
$99.1k
Paid exercise price by delivering 9,517 shares
@ $9.09, valued at
$86.5k
Paid exercise price by delivering 1,540 shares
@ $9.09, valued at
$14k
Paid exercise price by delivering 5,374 shares
@ $9.09, valued at
$48.8k
Paid exercise price by delivering 2,696 shares
@ $9.09, valued at
$24.5k
Exercised 13,462 options to buy
@ $1.04, valued at
$14k
Exercised 13,458 options to buy
@ $3.63, valued at
$48.9k
Exercised 19,396 options to buy
@ $4.46, valued at
$86.5k
Exercised 14,633 options to buy
@ $6.77, valued at
$99.1k
Exercised 3,594 options to buy
@ $6.82, valued at
$24.5k
|
|
| 05/10/2012 |
4
| Drazba Brian G. (VP, Finance & CAO) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 7,814 shares
@ $9.08, valued at
$71k
Paid exercise price by delivering 2,995 shares
@ $9.08, valued at
$27.2k
Paid exercise price by delivering 1,219 shares
@ $9.08, valued at
$11.1k
Paid exercise price by delivering 2,144 shares
@ $9.08, valued at
$19.5k
Exercised 7,492 options to buy
@ $3.63, valued at
$27.2k
Exercised 19,125 options to buy
@ $3.71, valued at
$71k
Exercised 2,416 options to buy
@ $4.58, valued at
$11.1k
Exercised 4,250 options to buy
@ $4.58, valued at
$19.5k
|
|
| 05/10/2012 |
4
| SILVERNAIL LAUREN P (CFO) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,285 shares
@ $9.08, valued at
$84.3k
Paid exercise price by delivering 39,172 shares
@ $9.08, valued at
$355.7k
Paid exercise price by delivering 12,826 shares
@ $9.08, valued at
$116.5k
Paid exercise price by delivering 11,224 shares
@ $9.08, valued at
$101.9k
Paid exercise price by delivering 1,907 shares
@ $9.08, valued at
$17.3k
Paid exercise price by delivering 4,502 shares
@ $9.08, valued at
$40.9k
Paid exercise price by delivering 1,661 shares
@ $9.08, valued at
$15.1k
Exercised 16,649 options to buy
@ $1.04, valued at
$17.3k
Exercised 11,262 options to buy
@ $3.63, valued at
$40.9k
Exercised 18,903 options to buy
@ $4.46, valued at
$84.3k
Exercised 65,867 options to buy
@ $5.4, valued at
$355.7k
|
|
| 05/10/2012 |
4
| ANIDO VICENTE JR (President & CEO) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 11,172 shares
@ $9.08, valued at
$101.4k
Paid exercise price by delivering 11,013 shares
@ $9.08, valued at
$100k
Paid exercise price by delivering 10,553 shares
@ $9.08, valued at
$95.8k
Paid exercise price by delivering 10,159 shares
@ $9.08, valued at
$92.2k
Paid exercise price by delivering 1,953 shares
@ $9.08, valued at
$17.7k
Paid exercise price by delivering 1,241 shares
@ $9.08, valued at
$11.3k
Exercised 17,051 options to buy
@ $1.04, valued at
$17.7k
Exercised 28,653 options to buy
@ $3.49, valued at
$100k
Exercised 3,103 options to buy
@ $3.63, valued at
$11.3k
Exercised 22,744 options to buy
@ $4.46, valued at
$101.4k
Exercised 14,154 options to buy
@ $6.77, valued at
$95.8k
|
|
| 04/27/2012 |
4/A
| MCGRAW BENJAMIN F III (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Granted 2,466 shares
@ $0.001, valued at
$2.5 |
|
| 04/27/2012 |
4/A
| WILLIAMS RICHARD C (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Granted 2,466 shares
@ $0.001, valued at
$2.5 |
|
| 04/27/2012 |
4/A
| ROE WAYNE I (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 04/27/2012 |
4
| ROE WAYNE I (Director) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 374 shares
@ $5.88, valued at
$2.2k
|
|
| 04/02/2012 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 03/23/2012 |
4
| CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed of 674,116 shares
@ $0 |
|
| 03/16/2012 |
4/A
| CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Sold 7,248 shares
@ $4.1047, valued at
$29.8k
Sold 1,397 shares
@ $4.1107, valued at
$5.7k
Disposed of 1,002,553 shares
@ $0 |
|
| 03/16/2012 |
4
| CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Sold 28,571 shares
@ $8.6994, valued at
$248.6k
Sold 130,256 shares
@ $8.581, valued at
$1.1M
Sold 157,043 shares
@ $8.5825, valued at
$1.3M
Sold 145,573 shares
@ $8.5159, valued at
$1.2M
Sold 4,373 shares
@ $8.59, valued at
$37.6k
|
|
| 03/12/2012 |
4
| CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Sold 200,886 shares
@ $8.3017, valued at
$1.7M
Sold 4,373 shares
@ $8.3013, valued at
$36.3k
Sold 17,391 shares
@ $8.3755, valued at
$145.7k
|
|
| 03/05/2012 |
4
| Davis Glenn Eugene (VP Legal, Chief Compl. Officer) has filed a Form 4 on ISTA PHARMACEUTICALS INC |
| 03/02/2012 |
4
| CREDIT SUISSE AG/ (10% Owner) has filed a Form 4 on ISTA PHARMACEUTICALS INC|
Txns:
| Disposed of 1,002,553 shares
@ $0 |
|
|
|
|